101 related articles for article (PubMed ID: 6195037)
1. Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion.
Gentilini P; Laffi G; Fantini F; di Donato M; Dabizzi RP; La Villa G; Pinzani M; Buzzelli G; Smorlesi C; Pampana A
Digestion; 1983; 27(3):138-45. PubMed ID: 6195037
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive factors in the mechanism of renal sodium handling in cirrhotics: the effect of acute plasma expansion.
Laffi G; La Villa G; Pinzani ; Mannelli M; Buzzelli G; Paladini S; Pampana A; Smorlesi C; Pedretti G; Gentilini P
Pharmacol Res Commun; 1984 Jun; 16(6):613-35. PubMed ID: 6431453
[TBL] [Abstract][Full Text] [Related]
4. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
6. Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion.
Tristani FE; Cohn JN
J Clin Invest; 1967 Dec; 46(12):1894-906. PubMed ID: 6073996
[TBL] [Abstract][Full Text] [Related]
7. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
[TBL] [Abstract][Full Text] [Related]
8. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
9. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. A safe and inexpensive option.
Terg R; Berreta J; Abecasis R; Romero G; Boerr L
Dig Dis Sci; 1992 Jan; 37(1):79-83. PubMed ID: 1370217
[TBL] [Abstract][Full Text] [Related]
10. [Directional velocity of the arterial flow, systemic vascular resistance and urinary excretion of sodium in cirrhotic patients].
Aliaga L; Mediavilla JD; Omar M; Zozaya JM; Prieto J
Presse Med; 1995 Apr; 24(16):758-62. PubMed ID: 7784414
[TBL] [Abstract][Full Text] [Related]
11. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of ascitic fluid pressure in cirrhotics to optimize hemodynamic and renal function.
Savino JA; Cerabona T; Agarwal N; Byrne D
Ann Surg; 1988 Oct; 208(4):504-11. PubMed ID: 3263091
[TBL] [Abstract][Full Text] [Related]
13. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
Domenicali M; Caraceni P; Giannone F; Pertosa AM; Principe A; Zambruni A; Trevisani F; Croci T; Bernardi M
Gastroenterology; 2009 Jul; 137(1):341-9. PubMed ID: 19208344
[TBL] [Abstract][Full Text] [Related]
15. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
16. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
[TBL] [Abstract][Full Text] [Related]
17. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion.
La Villa G; Laffi G; Pinzani M; Pampana A; Mannelli M; Smorlesi C; Gentilini P
Boll Soc Ital Biol Sper; 1984 Mar; 60(3):535-41. PubMed ID: 6561965
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
[TBL] [Abstract][Full Text] [Related]
20. Volume expansion enhances the recovery of renal function and prolongs the diuresis and natriuresis after release of bilateral ureteral obstruction: a possible role for atrial natriuretic peptide.
Gulmi FA; Matthews GJ; Marion D; von Lutterotti N; Vaughan ED
J Urol; 1995 Apr; 153(4):1276-83. PubMed ID: 7869528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
